speb/financial-data huggingface dataset:
Financial ratios for CJT.TO — annual report dated 2022-12-31
Total revenue: 720514705.882353
Gross profit: 181985294.11764705
Operating income: 126764705.88235293
Net income: 140147058.8235294
Capital expenditures: 448897058.82352936
Operating cash flow: 206250000
Depreciation & amortization: 104558823.52941176
Net tangible assets: 574411764.7058823
Owner earnings: -204191176.4705882
Return on net tangible assets (%): -35.54787506400409
Capex to operating income (%): 354.1183294663573
Buffett classification: The Gruesome
Stock price: 81.58088235294117
P/E ratio: 8.685795259968522
Shares outstanding: 14921249
Book value: 611397058.8235294
P/B ratio: 1.9909952814792546
Market cap (USD): 1217288659.227941
Debt to equity: 0.8502705953096813
Current ratio: 0.7714285714285715
Quick ratio: 0.7495016611295682
Effective tax rate (%): 13.363636363636367
Interest coverage ratio: 5.130952380952381
COGS to revenue (%): 74.74232064496378
SG&A to revenue (%): 7.439534646392489
Free cash flow (dilution-adjusted): -240147058.8235294
Buyback yield (%): 1.0087510198685359
Retained earnings: 122647058.8235294
Inventory turnover: 221.93939393939397
Receivables turnover: 10.239289446185998
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 9.391001198387624
FCF margin (%): -33.32993162567608
Rule of 40 score: -33.32993162567608
Financial ratios for CJT.TO — annual report dated 2023-12-31
Total revenue: 664772727.2727273
Gross profit: 104621212.12121211
Operating income: 49015151.515151516
Net income: 28257575.757575758
Capital expenditures: 105833333.33333333
Operating cash flow: 145378787.87878788
Depreciation & amortization: 135227272.72727272
Net tangible assets: 556212121.2121211
Owner earnings: 57651515.15151514
Return on net tangible assets (%): 10.365023154453826
Capex to operating income (%): 215.91962905718702
Buffett classification: The Gruesome
Stock price: 87.06060606060606
P/E ratio: 45.97184812546917
Shares outstanding: 14921249
Book value: 594318181.8181818
P/B ratio: 2.1857870428043342
Market cap (USD): 1299052981.1212122
Debt to equity: 1.018738049713193
Current ratio: 1.4927536231884058
Quick ratio: 1.478797638217928
Effective tax rate (%): 27.852998065764023
Interest coverage ratio: 1.1390845070422535
COGS to revenue (%): 84.26210826210826
SG&A to revenue (%): 8.136752136752136
Free cash flow (dilution-adjusted): -67196969.69696969
Buyback yield (%): 2.0702727128748237
Retained earnings: 121818181.81818181
Inventory turnover: 284.3846153846154
Receivables turnover: 7.3615771812080535
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.497297297297297
FCF margin (%): -10.108262108262107
Revenue growth (%): -7.736410951024691
Rule of 40 score: -17.844673059286798
Financial ratios for CJT.TO — quarterly report dated 2024-09-30
Capital expenditures: 0
Depreciation & amortization: 30740740.74074074
Buffett classification: The Gruesome
Stock price: 99.46666666666665
Shares outstanding: 14921249
Market cap (USD): 1484166900.533333
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CJT.TO — annual report dated 2024-12-31
Total revenue: 699860139.8601398
Gross profit: 157902097.9020979
Operating income: 94545454.54545455
Net income: 75804195.8041958
Capital expenditures: 101328671.32867134
Operating cash flow: 229790209.7902098
Depreciation & amortization: 132307692.30769232
Net tangible assets: 480699300.6993007
Owner earnings: 106783216.78321677
Return on net tangible assets (%): 22.214140238580153
Capex to operating income (%): 107.17455621301777
Buffett classification: The Gruesome
Stock price: 73.57342657342657
P/E ratio: 14.482145823708485
Shares outstanding: 14921249
Book value: 515874125.87412596
P/B ratio: 2.128052876901179
Market cap (USD): 1097807417.6853147
Debt to equity: 1.0235868239121593
Current ratio: 0.5824898785425101
Quick ratio: 0.569838056680162
Effective tax rate (%): 21.278140885984023
Interest coverage ratio: 2.380281690140845
COGS to revenue (%): 77.43804956035173
SG&A to revenue (%): 8.872901678657076
Free cash flow (dilution-adjusted): 48181818.18181819
Buyback yield (%): 8.134459456375914
Retained earnings: 93706293.70629372
Inventory turnover: 310.00000000000006
Receivables turnover: 9.707080504364693
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 7.823621318210751
FCF margin (%): 6.8844924060751405
Revenue growth (%): 5.278106508875742
Rule of 40 score: 12.162598914950882
Financial ratios for CJT.TO — quarterly report dated 2024-12-31
Total revenue: 205034965.03496504
Gross profit: 51468531.468531474
Operating income: 33706293.70629371
Net income: 49790209.79020979
Capital expenditures: 95734265.73426574
Operating cash flow: 72447552.44755246
Depreciation & amortization: 33706293.70629371
Net tangible assets: 480699300.6993007
Owner earnings: -12237762.237762243
Return on net tangible assets (%): -2.54582484725051
Capex to operating income (%): 284.0248962655602
Buffett classification: The Gruesome
Stock price: 73.57342657342657
P/E ratio: 5.512165053686798
Shares outstanding: 14921249
Book value: 515874125.87412596
P/B ratio: 2.128052876901179
Market cap (USD): 1097807417.6853147
Debt to equity: 1.0235868239121593
Current ratio: 0.5824898785425101
Quick ratio: 0.569838056680162
Effective tax rate (%): 7.891332470892626
Interest coverage ratio: 3.544117647058824
COGS to revenue (%): 74.89768076398363
SG&A to revenue (%): 15.72305593451569
Free cash flow (dilution-adjusted): -20209790.20979021
Buyback yield (%): 0.3694586127406445
Retained earnings: 93706293.70629372
Inventory turnover: 87.84
Receivables turnover: 2.8438409311348205
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.7891904403680345
FCF margin (%): -9.856753069577081
Rule of 40 score: -9.856753069577081
Financial ratios for CJT.TO — quarterly report dated 2025-03-31
Total revenue: 174755244.75524476
Gross profit: 36923076.92307693
Operating income: 24965034.965034965
Net income: 33566433.56643357
Capital expenditures: 77412587.41258742
Operating cash flow: 45314685.314685315
Depreciation & amortization: 33846153.84615385
Net tangible assets: 510489510.48951054
Owner earnings: -10000000
Return on net tangible assets (%): -1.958904109589041
Capex to operating income (%): 310.0840336134454
Buffett classification: The Gruesome
Stock price: 56.5944055944056
P/E ratio: 6.289461883177084
Shares outstanding: 14921249
Book value: 545664335.6643357
P/B ratio: 1.5475800097013968
Market cap (USD): 844459217.881119
Debt to equity: 1.077021658336537
Current ratio: 0.6626436781609195
Quick ratio: 0.646551724137931
Effective tax rate (%): 3.8076152304609217
Interest coverage ratio: 2.9749999999999996
COGS to revenue (%): 78.87154861944778
SG&A to revenue (%): 6.64265706282513
Free cash flow (dilution-adjusted): -30559440.55944056
Buyback yield (%): 2.6168110466422774
Retained earnings: 123006993.00699301
Inventory turnover: 70.39285714285714
Receivables turnover: 2.6332982086406744
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.9675925925925923
FCF margin (%): -17.486994797919166
Revenue growth (%): -14.76807639836289
Rule of 40 score: -32.25507119628206
Financial ratios for CJT.TO — quarterly report dated 2025-06-30
Total revenue: 173868613.13868612
Gross profit: 36131386.861313865
Operating income: 18686131.386861313
Net income: -2335766.423357664
Capital expenditures: 73357664.23357664
Operating cash flow: 20437956.204379562
Depreciation & amortization: 35839416.05839416
Net tangible assets: 497372262.7737226
Owner earnings: -39854014.59854015
Return on net tangible assets (%): -8.012914587613738
Capex to operating income (%): 392.578125
Buffett classification: The Gruesome
Stock price: 68.04379562043795
P/E ratio: 12.53131854143818
Shares outstanding: 14921249
Book value: 534087591.24087596
P/B ratio: 1.9009960800601333
Market cap (USD): 1015298417.3576641
Debt to equity: 1.31160311603116
Current ratio: 0.7723988439306358
Quick ratio: 0.7579479768786128
Effective tax rate (%): 252.38095238095238
Interest coverage ratio: 2.1880341880341883
COGS to revenue (%): 79.21914357682618
SG&A to revenue (%): 9.865659109991604
Free cash flow (dilution-adjusted): -55693430.6569343
Buyback yield (%): 2.8900927246391865
Retained earnings: 104744525.54744525
Inventory turnover: 47.175
Receivables turnover: 2.314868804664723
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.4284120075884386
FCF margin (%): -32.03190596137699
Revenue growth (%): -0.5073562271624077
Rule of 40 score: -32.5392621885394
Financial ratios for CJT.TO — quarterly report dated 2025-12-31
Total revenue: 207810218.97810218
Gross profit: 48905109.48905109
Operating income: 12846715.328467153
Net income: 19416058.394160584
Capital expenditures: 54890510.9489051
Operating cash flow: 21678832.11678832
Depreciation & amortization: 38978102.18978102
Net tangible assets: 505182481.7518248
Owner earnings: 3503649.6350364983
Return on net tangible assets (%): 0.6935413957520594
Capex to operating income (%): 427.27272727272725
Buffett classification: The Gruesome
Stock price: 60.700729927007295
P/E ratio: 9.017904646032342
Shares outstanding: 14921249
Book value: 541897810.2189782
P/B ratio: 1.6714049930495687
Market cap (USD): 905730705.7226276
Debt to equity: 1.3397090517241377
Current ratio: 1.227979274611399
Quick ratio: 1.2046632124352332
Effective tax rate (%): 19.148936170212767
Interest coverage ratio: 1.5042735042735045
COGS to revenue (%): 76.46645591851072
SG&A to revenue (%): 9.65929048120829
Free cash flow (dilution-adjusted): -36058394.160583936
Buyback yield (%): 1.1927297639103667
Retained earnings: 117518248.17518248
Inventory turnover: 48.37777777777777
Receivables turnover: 1.5167820990942993
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.9070294784580499
FCF margin (%): -17.35159817351598
Revenue growth (%): 19.521410579345087
Rule of 40 score: 2.1698124058291057
Financial ratios for CJT.TO — annual report dated 2025-12-31
Total revenue: 724598540.1459854
Gross profit: 145182481.7518248
Operating income: 66423357.66423357
Net income: 58540145.98540145
Capital expenditures: 255182481.7518248
Operating cash flow: 171240875.91240874
Depreciation & amortization: 151167883.21167883
Net tangible assets: 505182481.7518248
Owner earnings: -45474452.55474451
Return on net tangible assets (%): -9.001589365698596
Capex to operating income (%): 384.1758241758242
Buffett classification: The Gruesome
Stock price: 60.700729927007295
P/E ratio: 15.471958439401497
Shares outstanding: 14921249
Book value: 541897810.2189782
P/B ratio: 1.6714049930495687
Market cap (USD): 905730705.7226276
Debt to equity: 1.3397090517241377
Current ratio: 1.227979274611399
Quick ratio: 1.2046632124352332
Effective tax rate (%): 15.22198731501057
Interest coverage ratio: 1.8309859154929577
COGS to revenue (%): 79.96373526745239
SG&A to revenue (%): 8.522212148685403
Free cash flow (dilution-adjusted): -93722627.73722628
Buyback yield (%): 6.9790809158539036
Retained earnings: 117518248.17518248
Inventory turnover: 176.39999999999998
Receivables turnover: 5.288758657432072
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 4.68975468975469
FCF margin (%): -12.934421275309763
Revenue growth (%): 3.5347634301318034
Rule of 40 score: -9.399657845177959
Financial ratios for CLNE — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 6.13
Shares outstanding: 220224634
Market cap (USD): 1349977006.42
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CLNE — annual report dated 2022-12-31
Total revenue: 420164000
Gross profit: 57749000
Operating income: -51707000
Net income: -58733000
Capital expenditures: 53144000
Operating cash flow: 66731000
Depreciation & amortization: 54674000
Net tangible assets: 649750000
Owner earnings: -57203000
Return on net tangible assets (%): -8.80384763370527
Buffett classification: The Gruesome
Stock price: 5.2
Shares outstanding: 220224634
Book value: 727471000
P/B ratio: 1.574176973102708
Market cap (USD): 1145168096.8
Debt to equity: 0.2773485128616811
Current ratio: 3.184156170264469
Quick ratio: 2.9334305347427536
Interest coverage ratio: -8.197051363348129
COGS to revenue (%): 86.25560495425596
SG&A to revenue (%): 26.050780171552063
Free cash flow (dilution-adjusted): -37548000
Buyback yield (%): 0.5345940056404827
Retained earnings: -829975000
Inventory turnover: 9.757026706870558
Receivables turnover: 3.8740503061149223
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -5.53483099642372
FCF margin (%): -8.936510505421692
Rule of 40 score: -8.936510505421692
Financial ratios for CLNE — annual report dated 2023-12-31
Total revenue: 425159000
Gross profit: 35865000
Operating income: -76400000
Net income: -99497000
Capital expenditures: 121020000
Operating cash flow: 43777000
Depreciation & amortization: 45674000
Net tangible assets: 656077000
Owner earnings: -174843000
Return on net tangible assets (%): -26.64976824366652
Buffett classification: The Gruesome
Stock price: 3.83
Shares outstanding: 220224634
Book value: 733647000
P/B ratio: 1.1496814520062102
Market cap (USD): 843460348.22
Debt to equity: 0.4913943626839611
Current ratio: 2.8700182514054804
Quick ratio: 2.5932866569407227
Interest coverage ratio: -3.332751701273774
COGS to revenue (%): 91.56433240270111
SG&A to revenue (%): 26.405415385773324
Free cash flow (dilution-adjusted): -161450000
Buyback yield (%): 0
Retained earnings: -929472000
Inventory turnover: 8.58705194661961
Receivables turnover: 3.5970675826593115
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -6.973125173985863
FCF margin (%): -37.974028539910954
Revenue growth (%): 1.1888215077921953
Rule of 40 score: -36.785207032118755
Financial ratios for CLNE — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 3.11
Shares outstanding: 220224634
Market cap (USD): 684898611.74
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CLNE — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 2.51
Shares outstanding: 220224634
Market cap (USD): 552763831.3399999
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CLNE — annual report dated 2024-12-31
Total revenue: 415865000
Gross profit: 83583000
Operating income: -28251000
Net income: -83070000
Capital expenditures: 79380000
Operating cash flow: 64579000
Depreciation & amortization: 44737000
Net tangible assets: 642580000
Owner earnings: -117713000
Return on net tangible assets (%): -18.318808553020634
Buffett classification: The Gruesome
Stock price: 2.51
Shares outstanding: 220224634
Book value: 719531000
P/B ratio: 0.7682279586841984
Market cap (USD): 552763831.3399999
Debt to equity: 0.5074541611132808
Current ratio: 2.6742673957161878
Quick ratio: 2.3935445508718862
Interest coverage ratio: -0.8779328133254607
COGS to revenue (%): 79.90141031344307
SG&A to revenue (%): 26.89190001563007
Free cash flow (dilution-adjusted): -86944000
Buyback yield (%): 0
Retained earnings: -1012542000
Inventory turnover: 7.650273978910531
Receivables turnover: 3.335325019048001
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -2.5938123468442456
FCF margin (%): -20.906784653673668
Revenue growth (%): -2.1860057061005413
Rule of 40 score: -23.09279035977421
Financial ratios for CLNE — quarterly report dated 2025-03-31
Total revenue: 103764000
Gross profit: -34506000
Operating income: -61970000
Net income: -134967000
Capital expenditures: 13592000
Operating cash flow: 23428000
Depreciation & amortization: 62267000
Net tangible assets: 591204000
Owner earnings: -86292000
Return on net tangible assets (%): -14.595977023159518
Buffett classification: The Gruesome
Stock price: 1.55
Shares outstanding: 220224634
Book value: 602898000
P/B ratio: 0.566178993295715
Market cap (USD): 341348182.7
Debt to equity: 0.6109093080421564
Current ratio: 2.818739223394717
Quick ratio: 2.5034071315263122
Interest coverage ratio: -8.23193411264612
COGS to revenue (%): 133.25430785243438
SG&A to revenue (%): 26.467753748891713
Free cash flow (dilution-adjusted): -14277000
Buyback yield (%): 0.11454579804915423
Retained earnings: -1147509000
Inventory turnover: 3.024278215223097
Receivables turnover: 0.9487688242340011
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -6.3781260227953425
FCF margin (%): -13.759107204810917
Rule of 40 score: -13.759107204810917
Financial ratios for CLNE — quarterly report dated 2025-06-30
Total revenue: 102613000
Gross profit: 18221000
Operating income: -9232000
Net income: -20240000
Capital expenditures: 14698000
Operating cash flow: 35901000
Depreciation & amortization: 9962000
Net tangible assets: 585321000
Owner earnings: -24976000
Return on net tangible assets (%): -4.267060296828578
Buffett classification: The Gruesome
Stock price: 1.95
Shares outstanding: 220224634
Book value: 596847000
P/B ratio: 0.7195110912847011
Market cap (USD): 429438036.3
Debt to equity: 0.6263313713564783
Current ratio: 2.8274547319967835
Quick ratio: 2.512914898926878
Interest coverage ratio: -1.193535875888817
COGS to revenue (%): 82.2429906542056
SG&A to revenue (%): 26.75392006860729
Free cash flow (dilution-adjusted): 1394000
Buyback yield (%): 1.7574130286698126
Retained earnings: -1167749000
Inventory turnover: 1.8599607696206995
Receivables turnover: 1.0880740560085678
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.9501940631397368
FCF margin (%): 1.3585023340122597
Revenue growth (%): -1.1092479087159324
Rule of 40 score: 0.24925442529632735
Financial ratios for CLNE — quarterly report dated 2025-09-30
Total revenue: 106137000
Gross profit: 12634000
Operating income: -13636000
Net income: -23819000
Capital expenditures: 12091000
Operating cash flow: 13088000
Depreciation & amortization: 14682000
Net tangible assets: 579707000
Owner earnings: -21228000
Return on net tangible assets (%): -3.6618498655355207
Buffett classification: The Gruesome
Stock price: 2.58
Shares outstanding: 220224634
Book value: 591049000
P/B ratio: 0.9613070248321206
Market cap (USD): 568179555.72
Debt to equity: 0.6455556138323557
Current ratio: 2.685168167616247
Quick ratio: 2.393592301835272
Interest coverage ratio: -1.7522487792341301
COGS to revenue (%): 88.0965167660665
SG&A to revenue (%): 24.751029330016866
Free cash flow (dilution-adjusted): -18061000
Buyback yield (%): 0
Retained earnings: -1191568000
Inventory turnover: 2.10492784944058
Receivables turnover: 1.0150822494261669
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -1.4017932591384872
FCF margin (%): -17.01668598132602
Revenue growth (%): 3.4342627152505045
Rule of 40 score: -13.582423266075516
Financial ratios for CLNE — annual report dated 2025-12-31
Total revenue: 424833000
Gross profit: 16302000
Operating income: -95536000
Net income: -222024000
Capital expenditures: 54756000
Operating cash flow: 85529000
Depreciation & amortization: 98606000
Net tangible assets: 549525000
Owner earnings: -178174000
Return on net tangible assets (%): -32.42327464628543
Buffett classification: The Gruesome
Stock price: 2.1
Shares outstanding: 220224634
Book value: 565067000
P/B ratio: 0.8184369842868191
Market cap (USD): 462471731.40000004
Debt to equity: 0.5762644075835255
Current ratio: 2.3177466838675533
Quick ratio: 2.0272766365651154
Interest coverage ratio: -1.81327462182322
COGS to revenue (%): 96.16272747173595
SG&A to revenue (%): 26.325167771806807
Free cash flow (dilution-adjusted): -49325000
Buyback yield (%): 1.7244297237061352
Retained earnings: -1234566000
Inventory turnover: 9.304673620917415
Receivables turnover: 3.970921428972015
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -10.54992430106862
FCF margin (%): -11.610444574691703
Revenue growth (%): 2.156469046445361
Rule of 40 score: -9.453975528246342
Financial ratios for CLNE — quarterly report dated 2025-12-31
Total revenue: 112319000
Gross profit: 19953000
Operating income: -10698000
Net income: -42998000
Capital expenditures: 14375000
Operating cash flow: 13112000
Depreciation & amortization: 11695000
Net tangible assets: 549525000
Owner earnings: -45678000
Return on net tangible assets (%): -8.312269687457349
Buffett classification: The Gruesome
Stock price: 2.1
Shares outstanding: 220224634
Book value: 565067000
P/B ratio: 0.8184369842868191
Market cap (USD): 462471731.40000004
Debt to equity: 0.5762644075835255
Current ratio: 2.3177466838675533
Quick ratio: 2.0272766365651154
Interest coverage ratio: -0.36090682140206465
COGS to revenue (%): 82.23541876263143
SG&A to revenue (%): 27.289238686241863
Free cash flow (dilution-adjusted): -18381000
Buyback yield (%): 0.008000489000266708
Retained earnings: -1234566000
Inventory turnover: 2.10372158702683
Receivables turnover: 1.0498476436169217
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -1.1813671304307496
FCF margin (%): -16.364996127102273
Revenue growth (%): 5.824547518772906
Rule of 40 score: -10.540448608329367
Financial ratios for CMX.AX — annual report dated 2022-06-30
Operating income: -1518228.9655172415
Net income: -1300359.3103448276
Capital expenditures: 6672.413793103448
Depreciation & amortization: 44857.24137931035
Net tangible assets: 6158366.206896552
Owner earnings: -1262174.4827586208
Return on net tangible assets (%): -20.495281383967605
Buffett classification: The Gruesome
Stock price: 0.09655172413793105
Shares outstanding: 1290223210
Book value: 7010458.620689656
P/B ratio: 17.769632799861096
Market cap (USD): 124573275.44827588
Debt to equity: 0
Current ratio: 21.721528125799473
Quick ratio: 21.721528125799473
Free cash flow (dilution-adjusted): -1455325.5172413792
Buyback yield (%): 0.5888853692444204
Retained earnings: -1381266.2068965517
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -21.6564685142702
Rule of 40 score: 0
Financial ratios for CMX.AX — annual report dated 2023-06-30
Operating income: -3439608.609271523
Net income: -2769739.072847682
Capital expenditures: 26972.185430463574
Depreciation & amortization: 166443.70860927153
Net tangible assets: 3699962.913907285
Owner earnings: -2630267.549668874
Return on net tangible assets (%): -71.08902469758064
Buffett classification: The Gruesome
Stock price: 0.046357615894039736
Shares outstanding: 1290223210
Book value: 4432104.63576159
P/B ratio: 13.49509474666932
Market cap (USD): 59811671.98675497
Debt to equity: 0.08855852794734625
Current ratio: 2.259296380589859
Quick ratio: 2.259296380589859
Interest coverage ratio: -143.21822694057633
Free cash flow (dilution-adjusted): -3219430.463576159
Buyback yield (%): 0.0576666553245908
Retained earnings: -4096120.5298013245
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -72.45814146821442
Rule of 40 score: 0
Financial ratios for CMX.AX — annual report dated 2024-06-30
Operating income: -3053516
Net income: -2990365.3333333335
Capital expenditures: 992.6666666666666
Depreciation & amortization: 185286
Net tangible assets: 2299374
Owner earnings: -2806072
Return on net tangible assets (%): -122.03634554448297
Buffett classification: The Gruesome
Stock price: 0.03333333333333333
Shares outstanding: 1290223210
Book value: 2949729.9999999995
P/B ratio: 14.580127785706942
Market cap (USD): 43007440.333333336
Debt to equity: 0.5339331622442282
Current ratio: 0.46397220171418657
Quick ratio: 0.46397220171418657
Interest coverage ratio: -5.962306936299555
Free cash flow (dilution-adjusted): -2349768
Buyback yield (%): 0.26644846979616804
Retained earnings: -7014873.333333333
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -95.81902584239342
Rule of 40 score: 0
Financial ratios for CNQ — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 16.89
Shares outstanding: 2085710000
Market cap (USD): 35227641900
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CNQ — annual report dated 2022-12-31
Total revenue: 36419117647.05882
Gross profit: 11955882352.941175
Operating income: 10852941176.470587
Net income: 8041911764.705882
Capital expenditures: 3776470588.235294
Operating cash flow: 14258088235.294117
Depreciation & amortization: 5406617647.058824
Net tangible assets: 28069852941.176468
Owner earnings: 9672058823.529411
Return on net tangible assets (%): 34.457105435494434
Capex to operating income (%): 34.79674796747968
Buffett classification: The Good
Stock price: 24.14
P/E ratio: 6.260829622748469
Shares outstanding: 2085710000
Book value: 28069852941.176468
P/B ratio: 1.793705136450557
Market cap (USD): 50349039400
Debt to equity: 0.29980353634577606
Current ratio: 0.8157438446422378
Quick ratio: 0.6059415096520633
Effective tax rate (%): 20.19118505545826
Interest coverage ratio: 22.029850746268657
COGS to revenue (%): 67.17141126589945
SG&A to revenue (%): 2.461134665859075
Free cash flow (dilution-adjusted): 9890441176.470587
Buyback yield (%): 8.135852398033565
Retained earnings: 20347058823.52941
Inventory turnover: 18.330578512396695
Receivables turnover: 13.932489451476794
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 21.869582611014803
FCF margin (%): 27.157278417120935
Rule of 40 score: 27.157278417120935
Financial ratios for CNQ — annual report dated 2023-12-31
Total revenue: 30935606060.60606
Gross profit: 8918939393.939394
Operating income: 7927272727.272727
Net income: 6237121212.121212
Capital expenditures: 33333333.333333332
Operating cash flow: 9358333333.333332
Depreciation & amortization: 4858333333.333333
Net tangible assets: 30175757575.757576
Owner earnings: 11062121212.12121
Return on net tangible assets (%): 36.65896766418959
Capex to operating income (%): 0.4204892966360856
Buffett classification: The Great
Stock price: 29.87
P/E ratio: 9.988607817806388
Shares outstanding: 2085710000
Book value: 30175757575.757576
P/B ratio: 2.0645764250853587
Market cap (USD): 62300157700
Debt to equity: 0.27111367744527015
Current ratio: 0.9639542703429724
Quick ratio: 0.690383322125084
Effective tax rate (%): 19.006394490900146
Interest coverage ratio: 15.143270622286542
COGS to revenue (%): 71.16934002693766
SG&A to revenue (%): 2.3092934982245623
Free cash flow (dilution-adjusted): 5267424242.424242
Buyback yield (%): 4.03471910254308
Retained earnings: 21930303030.30303
Inventory turnover: 14.288102261553588
Receivables turnover: 12.804954531201004
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 15.271453590192646
FCF margin (%): 17.027060119995102
Revenue growth (%): -15.05668434802293
Rule of 40 score: 1.9703757719721722
Financial ratios for CNQ — quarterly report dated 2024-09-30
Capital expenditures: 5925925.925925925
Buffett classification: The Gruesome
Stock price: 31.32
Shares outstanding: 2085710000
Market cap (USD): 65324437200
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CNQ — annual report dated 2024-12-31
Total revenue: 29027272727.272728
Gross profit: 7620979020.979021
Operating income: 6802097902.097902
Net income: 4269930069.93007
Capital expenditures: 64335664.33566434
Operating cash flow: 9360839160.83916
Depreciation & amortization: 4672027972.027972
Net tangible assets: 27600000000
Owner earnings: 8877622377.622377
Return on net tangible assets (%): 32.165298469646295
Capex to operating income (%): 0.9458209108666599
Buffett classification: The Great
Stock price: 29.48
P/E ratio: 14.399938592204387
Shares outstanding: 2085710000
Book value: 27599999999.999996
P/B ratio: 2.2277801014492757
Market cap (USD): 61486730800
Debt to equity: 0.4768166615992704
Current ratio: 0.7688713529228532
Quick ratio: 0.47887031460907475
Effective tax rate (%): 24.233775902717458
Interest coverage ratio: 14.453194650817236
COGS to revenue (%): 73.74545279337012
SG&A to revenue (%): 1.883928786528223
Free cash flow (dilution-adjusted): 5401398601.398602
Buyback yield (%): 3.0252703891355046
Retained earnings: 19652447552.44755
Inventory turnover: 10.959899749373434
Receivables turnover: 10.060349006301502
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 12.844654553137547
FCF margin (%): 18.608012720132983
Revenue growth (%): -6.16872780702828
Rule of 40 score: 12.439284913104704
Financial ratios for CNQ — quarterly report dated 2024-12-31
Total revenue: 7737062937.062938
Gross profit: 1999300699.3006995
Operating income: 1811188811.1888113
Net income: 795804195.8041959
Capital expenditures: 13286713.286713287
Net tangible assets: 27600000000
Owner earnings: 782517482.5174826
Return on net tangible assets (%): 2.835208269990879
Capex to operating income (%): 0.7335907335907336
Buffett classification: The Great
Stock price: 29.48
P/E ratio: 19.315910598418277
Shares outstanding: 2085710000
Book value: 27599999999.999996
P/B ratio: 2.2277801014492757
Market cap (USD): 61486730800
Debt to equity: 0.4768166615992704
Current ratio: 0.7688713529228532
Quick ratio: 0.47887031460907475
Effective tax rate (%): 28.24716267339218
Interest coverage ratio: 18.239436619718308
COGS to revenue (%): 74.15943600867678
SG&A to revenue (%): 1.5455531453362255
Buyback yield (%): 0
Retained earnings: 19652447552.44755
Inventory turnover: 2.9377013963480128
Receivables turnover: 2.6815317498788174
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.4201352207901965
Rule of 40 score: 0
Financial ratios for CNQ — quarterly report dated 2025-03-31
Total revenue: 8889510489.51049
Gross profit: 2487412587.4125876
Operating income: 2299300699.300699
Net income: 1718881118.881119
Capital expenditures: 906993006.9930071
Operating cash flow: 2995804195.804196
Depreciation & amortization: 1307692307.6923077
Net tangible assets: 28283216783.216785
Owner earnings: 2119580419.5804195
Return on net tangible assets (%): 7.494127827914451
Capex to operating income (%): 39.44647201946472
Buffett classification: The Good
Stock price: 29.81
P/E ratio: 9.042948697416598
Shares outstanding: 2085710000
Book value: 28283216783.21678
P/B ratio: 2.198300694597602
Market cap (USD): 62175015100
Debt to equity: 0.4309061688713068
Current ratio: 0.8369779011917158
Quick ratio: 0.5255119750086774
Effective tax rate (%): 20.632870519857928
Interest coverage ratio: 12.744186046511627
COGS to revenue (%): 72.01856513530522
SG&A to revenue (%): 1.4002517306482065
Free cash flow (dilution-adjusted): 2070629370.6293707
Buyback yield (%): 0.5477432373947917
Retained earnings: 20206293706.29371
Inventory turnover: 3.400817236255572
Receivables turnover: 3.2932642487046637
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 4.316603431752242
FCF margin (%): 23.29295154185022
Revenue growth (%): 14.895155459146784
Rule of 40 score: 38.188107000997
Financial ratios for CNQ — quarterly report dated 2025-06-30
Total revenue: 7062043795.620438
Gross profit: 1685401459.8540144
Operating income: 1503649635.0364962
Net income: 1794890510.948905
Capital expenditures: 1397810218.978102
Operating cash flow: 2272992700.729927
Depreciation & amortization: 1288321167.8832116
Net tangible assets: 30144525547.44525
Owner earnings: 1685401459.8540146
Return on net tangible assets (%): 5.591069785461766
Capex to operating income (%): 92.96116504854368
Buffett classification: The Gruesome
Stock price: 30.79
P/E ratio: 14.901469076843355
Shares outstanding: 2085710000
Book value: 30144525547.445255
P/B ratio: 2.130370597438133
Market cap (USD): 64219010900
Debt to equity: 0.41360356433725604
Current ratio: 0.8510513332550218
Quick ratio: 0.5377657699988253
Effective tax rate (%): 12.459950160199359
Interest coverage ratio: 8.655462184873949
COGS to revenue (%): 76.1343669250646
SG&A to revenue (%): 1.643410852713178
Free cash flow (dilution-adjusted): 869343065.6934305
Buyback yield (%): 0.4080470750763898
Retained earnings: 21758394160.58394
Inventory turnover: 2.7619047619047623
Receivables turnover: 2.4820420728578756
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.6838642433717674
FCF margin (%): 12.310077519379844
Revenue growth (%): -20.55756271446488
Rule of 40 score: -8.247485195085035
Financial ratios for CNQ — quarterly report dated 2025-09-30
Total revenue: 7964028776.978417
Gross profit: 1002877697.8417267
Operating income: 779856115.1079137
Net income: 431654676.25899285
Capital expenditures: 1482733812.9496403
Operating cash flow: 2834532374.1007195
Depreciation & amortization: 2310071942.4460435
Net tangible assets: 29108633093.52518
Owner earnings: 1258992805.755396
Return on net tangible assets (%): 4.325152616099454
Capex to operating income (%): 190.1291512915129
Buffett classification: The Gruesome
Stock price: 31.34
P/E ratio: 13.786748265856035
Shares outstanding: 2085710000
Book value: 29108633093.52518
P/B ratio: 2.2455932983861002
Market cap (USD): 65366151400
Debt to equity: 0.42678134499888787
Current ratio: 0.863827739684831
Quick ratio: 0.5307349933838565
Effective tax rate (%): -23.20328542094456
Interest coverage ratio: 11.655913978494624
COGS to revenue (%): 87.4074074074074
SG&A to revenue (%): 1.9421860885275521
Free cash flow (dilution-adjusted): 1306474820.143885
Buyback yield (%): 0.3400875736327676
Retained earnings: 20797841726.618706
Inventory turnover: 3.4944023113037197
Receivables turnover: 2.9559412550066755
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.402764118225581
FCF margin (%): 16.404697380307137
Revenue growth (%): 12.772293792872686
Rule of 40 score: 29.17699117317982
Financial ratios for CNQ — quarterly report dated 2025-12-31
Total revenue: 7817518248.175182
Gross profit: 1562773722.627737
Operating income: 1309489051.0948904
Net income: 3870802919.708029
Capital expenditures: 3649635.03649635
Operating cash flow: 2750364963.503649
Depreciation & amortization: 1852554744.5255473
Net tangible assets: 32383941605.839413
Owner earnings: 5719708029.19708
Return on net tangible assets (%): 17.66217373664518
Capex to operating income (%): 0.2787068004459309
Buffett classification: The Great
Stock price: 33.19
P/E ratio: 8.85653592035499
Shares outstanding: 2085710000
Book value: 32383941605.839417
P/B ratio: 2.1376247444664833
Market cap (USD): 69224714900
Debt to equity: 0.37454356939999095
Current ratio: 0.9505146967629914
Quick ratio: 0.6254495845218901
Effective tax rate (%): 22.561331775700932
Interest coverage ratio: 7.322448979591836
COGS to revenue (%): 80.00933706816059
SG&A to revenue (%): 2.26890756302521
Free cash flow (dilution-adjusted): 1628467153.2846713
Buyback yield (%): 0.3100027792905874
Retained earnings: 23887591240.87591
Inventory turnover: 3.269362838611217
Receivables turnover: 2.6781695423855965
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.141654828273664
FCF margin (%): 20.83099906629318
Revenue growth (%): -1.839653433030684
Rule of 40 score: 18.991345633262497
Financial ratios for CNQ — annual report dated 2025-12-31
Total revenue: 32238686131.38686
Gross profit: 6862043795.620438
Operating income: 6004379562.043796
Net income: 7897810218.978102
Capital expenditures: 83941605.83941606
Operating cash flow: 11026277372.262774
Depreciation & amortization: 5552554744.525547
Net tangible assets: 32383941605.839413
Owner earnings: 13366423357.664232
Return on net tangible assets (%): 41.27485011044493
Capex to operating income (%): 1.3980063214198881
Buffett classification: The Great
Stock price: 33.19
P/E ratio: 8.765051701756008
Shares outstanding: 2085710000
Book value: 32383941605.839417
P/B ratio: 2.1376247444664833
Market cap (USD): 69224714900
Debt to equity: 0.37454356939999095
Current ratio: 0.9505146967629914
Quick ratio: 0.6254495845218901
Effective tax rate (%): 18.284117513782945
Interest coverage ratio: 7.917228103946102
COGS to revenue (%): 78.7148776235651
SG&A to revenue (%): 1.7999864151968663
Free cash flow (dilution-adjusted): 5937956204.379561
Buyback yield (%): 1.5278708407893238
Retained earnings: 23887591240.87591
Inventory turnover: 13.26440289965662
Receivables turnover: 11.044511127781947
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 9.820096219274893
FCF margin (%): 18.418728915253467
Revenue growth (%): 11.063434840355606
Rule of 40 score: 29.482163755609072
Financial ratios for COCO — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 11.17
Shares outstanding: 57112643
Market cap (USD): 637948222.31
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for COCO — annual report dated 2022-12-31
Total revenue: 427787000
Gross profit: 103361000
Operating income: 3055000
Net income: 7814000
Capital expenditures: 982000
Operating cash flow: -10935000
Depreciation & amortization: 1901000
Net tangible assets: 133302000
Owner earnings: 8733000
Return on net tangible assets (%): 6.551289553044966
Capex to operating income (%): 32.144026186579374
Buffett classification: The Good
Stock price: 13.82
P/E ratio: 101.01058692858972
Shares outstanding: 57112643
Book value: 141093000
P/B ratio: 5.594159357728591
Market cap (USD): 789296726.26
Debt to equity: 0.005542443636466728
Current ratio: 3.21859934493799
Quick ratio: 1.6708313399330217
Effective tax rate (%): 27.921778433723826
Interest coverage ratio: 11.84108527131783
COGS to revenue (%): 75.83820920224316
SG&A to revenue (%): 23.447650349356106
Free cash flow (dilution-adjusted): -19301000
Buyback yield (%): 0
Retained earnings: 55183000
Inventory turnover: 3.8569339594602625
Receivables turnover: 7.43227700754022
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.130241055428105
FCF margin (%): -4.511824810010589
Rule of 40 score: -4.511824810010589
Financial ratios for COCO — annual report dated 2023-12-31
Total revenue: 493612000
Gross profit: 180729000
Operating income: 56493000
Net income: 46629000
Capital expenditures: 594000
Operating cash flow: 107155000
Depreciation & amortization: 660000
Net tangible assets: 194646000
Owner earnings: 46695000
Return on net tangible assets (%): 23.989704386424588
Capex to operating income (%): 1.0514577027242313
Buffett classification: The Great
Stock price: 25.65
P/E ratio: 31.41691421540243
Shares outstanding: 57112643
Book value: 202437000
P/B ratio: 7.2365194749477615
Market cap (USD): 1464939292.9499998
Debt to equity: 0.0060018672475881385
Current ratio: 3.183834836834776
Quick ratio: 2.569231700672035
Effective tax rate (%): 19.494129834254142
Interest coverage ratio: 1822.3548387096773
COGS to revenue (%): 63.3864249653574
SG&A to revenue (%): 25.168756027000967
Free cash flow (dilution-adjusted): 97428000
Buyback yield (%): 0.05276669167931066
Retained earnings: 100742000
Inventory turnover: 6.16433201331836
Receivables turnover: 7.476477537790434
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 27.815772758829528
FCF margin (%): 19.737769746278452
Revenue growth (%): 15.387330610794624
Rule of 40 score: 35.12510035707308
Financial ratios for COCO — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 28.31
Shares outstanding: 57112643
Market cap (USD): 1616858923.33
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for COCO — annual report dated 2024-12-31
Total revenue: 516013000
Gross profit: 198783000
Operating income: 73820000
Net income: 55952000
Capital expenditures: 974000
Operating cash flow: 42899000
Depreciation & amortization: 745000
Net tangible assets: 251026000
Owner earnings: 55723000
Return on net tangible assets (%): 22.198099001697035
Capex to operating income (%): 1.3194256299105933
Buffett classification: The Great
Stock price: 36.91
P/E ratio: 37.67564435819988
Shares outstanding: 57112643
Book value: 258817000
P/B ratio: 8.144857768732347
Market cap (USD): 2108027653.1299999
Debt to equity: 0.0016807242182700517
Current ratio: 3.3049696899269847
Quick ratio: 2.4954099122654116
Effective tax rate (%): 20.958354523365543
COGS to revenue (%): 61.4771333280363
SG&A to revenue (%): 24.217025540054223
Free cash flow (dilution-adjusted): 33003000
Buyback yield (%): 0.5706756257271034
Retained earnings: 156694000
Inventory turnover: 3.794617224880383
Receivables turnover: 6.387722512440891
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 28.48928082125697
FCF margin (%): 6.395769098840533
Revenue growth (%): 4.538179784932295
Rule of 40 score: 10.933948883772828
Financial ratios for COCO — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 36.91
Shares outstanding: 57112643
Market cap (USD): 2108027653.1299999
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for COCO — quarterly report dated 2025-03-31
Total revenue: 130921000
Gross profit: 48085000
Operating income: 19293000
Net income: 18882000
Capital expenditures: 559000
Operating cash flow: -9800000
Depreciation & amortization: 202000
Net tangible assets: 270067000
Owner earnings: 18525000
Return on net tangible assets (%): 6.859408961479929
Capex to operating income (%): 2.8974239361426424
Buffett classification: The Great
Stock price: 30.65
P/E ratio: 23.1768682865957
Shares outstanding: 57112643
Book value: 277858000
P/B ratio: 6.299989591625938
Market cap (USD): 1750502507.9499998
Debt to equity: 0.045321711089837256
Current ratio: 3.764601295988861
Quick ratio: 2.8184758742569485
Effective tax rate (%): 22.49722940524566
COGS to revenue (%): 63.27174402884182
SG&A to revenue (%): 21.99188823794502
Free cash flow (dilution-adjusted): -12545000
Buyback yield (%): 0.08574680659885542
Retained earnings: 175576000
Inventory turnover: 0.937748344370861
Receivables turnover: 1.7056110684089163
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 6.638931329231531
FCF margin (%): -9.582114404870111
Rule of 40 score: -9.582114404870111
Financial ratios for COCO — quarterly report dated 2025-06-30
Total revenue: 168759000
Gross profit: 61265000
Operating income: 25122000
Net income: 22908000
Capital expenditures: 949000
Operating cash flow: 21810000
Depreciation & amortization: 206000
Net tangible assets: 289148000
Owner earnings: 22165000
Return on net tangible assets (%): 7.66562452446498
Capex to operating income (%): 3.7775654804553778
Buffett classification: The Great
Stock price: 36.1
P/E ratio: 49.33635827470687
Shares outstanding: 57112643
Book value: 296939000
P/B ratio: 6.943400537820899
Market cap (USD): 2061766412.3000002
Debt to equity: 0.04716120145888549
Current ratio: 3.514480702997919
Quick ratio: 2.7501431258689784
Effective tax rate (%): 18.682332895530866
COGS to revenue (%): 63.69675098809545
SG&A to revenue (%): 21.416931837709395
Free cash flow (dilution-adjusted): 17899000
Buyback yield (%): 0.4147899562715172
Retained earnings: 198484000
Inventory turnover: 1.2780168826536678
Receivables turnover: 1.6456104767384034
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 8.07693049634445
FCF margin (%): 10.606249148193578
Revenue growth (%): 28.901398553326054
Rule of 40 score: 39.50764770151963
Financial ratios for COCO — quarterly report dated 2025-09-30
Total revenue: 182313000
Gross profit: 68668000
Operating income: 27923000
Net income: 24003000
Capital expenditures: 3413000
Operating cash flow: 39059000
Depreciation & amortization: 228000
Net tangible assets: 315942000
Owner earnings: 20818000
Return on net tangible assets (%): 6.589184090750834
Capex to operating income (%): 12.22289868567131
Buffett classification: The Great
Stock price: 42.47
P/E ratio: 36.86674795510161
Shares outstanding: 57112643
Book value: 323733000
P/B ratio: 7.492513732643876
Market cap (USD): 2425573948.21
Debt to equity: 0.043279492668340885
Current ratio: 3.4289671707558096
Quick ratio: 2.7451825331896935
Effective tax rate (%): 21.760813585840477
COGS to revenue (%): 62.33510501171063
SG&A to revenue (%): 22.348927394096965
Free cash flow (dilution-adjusted): 32671000
Buyback yield (%): 0.006225330714465886
Retained earnings: 222487000
Inventory turnover: 1.3462176313108578
Receivables turnover: 1.7634035226866047
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 8.265228497766675
FCF margin (%): 17.920279958094046
Revenue growth (%): 8.031571649512026
Rule of 40 score: 25.951851607606073
Financial ratios for COCO — annual report dated 2025-12-31
Total revenue: 609780000
Gross profit: 222595000
Operating income: 82532000
Net income: 71320000
Capital expenditures: 8149000
Operating cash flow: 47174000
Depreciation & amortization: 1072000
Net tangible assets: 323751000
Owner earnings: 64243000
Return on net tangible assets (%): 19.843336391238946
Capex to operating income (%): 9.873745940968352
Buffett classification: The Great
Stock price: 53.01
P/E ratio: 42.45010102958497
Shares outstanding: 57112643
Book value: 331542000
P/B ratio: 9.131697357891309
Market cap (USD): 3027541205.43
Debt to equity: 0.044691170349457986
Current ratio: 3.6196234712106636
Quick ratio: 2.6622577985433558
Effective tax rate (%): 23.287906981746996
COGS to revenue (%): 63.495850962642265
SG&A to revenue (%): 22.969431598281346
Free cash flow (dilution-adjusted): 28182000
Buyback yield (%): 0.37221623870184356
Retained earnings: 228014000
Inventory turnover: 3.4735080920084687
Receivables turnover: 5.8941568798028126
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 23.941333116736192
FCF margin (%): 4.621666830660238
Revenue growth (%): 18.171441417173597
Rule of 40 score: 22.793108247833835
Financial ratios for COCO — quarterly report dated 2025-12-31
Total revenue: 127787000
Gross profit: 44577000
Operating income: 10194000
Net income: 5527000
Capital expenditures: 3228000
Operating cash flow: -3895000
Depreciation & amortization: 436000
Net tangible assets: 323751000
Owner earnings: 2735000
Return on net tangible assets (%): 0.844785035413018
Capex to operating income (%): 31.665685697469097
Buffett classification: The Good
Stock price: 53.01
P/E ratio: 42.45010102958497
Shares outstanding: 57112643
Book value: 331542000
P/B ratio: 9.131697357891309
Market cap (USD): 3027541205.43
Debt to equity: 0.044691170349457986
Current ratio: 3.6196234712106636
Quick ratio: 2.6622577985433558
Effective tax rate (%): 43.35929493748719
COGS to revenue (%): 65.11616987643501
SG&A to revenue (%): 26.906492835734465
Free cash flow (dilution-adjusted): -9843000
Buyback yield (%): 0.03517706045056912
Retained earnings: 228014000
Inventory turnover: 0.7464922668389135
Receivables turnover: 1.2351940457203614
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.9571311708429304
FCF margin (%): -7.702661460085924
Revenue growth (%): -29.907905634814853
Rule of 40 score: -37.61056709490077
Financial ratios for CODI — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 25.94
Shares outstanding: 75235966
Market cap (USD): 1951620958.0400002
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CODI — annual report dated 2022-12-31
Total revenue: 1756809000
Gross profit: 649431000
Operating income: 73046000
Net income: -59223000
Capital expenditures: 60183000
Operating cash flow: -46645000
Depreciation & amortization: 112129000
Net tangible assets: -877463000
Owner earnings: -7277000
Capex to operating income (%): 82.39054842154259
Buffett classification: The Gruesome
Stock price: 16.15
Shares outstanding: 75235966
Book value: 928937000
P/B ratio: 1.308012115891605
Market cap (USD): 1215060850.8999999
Debt to equity: 1.9748034581462468
Current ratio: 2.22001553457537
Quick ratio: 0.9915806977431106
Interest coverage ratio: 0.875903831164938
COGS to revenue (%): 63.03348855794796
SG&A to revenue (%): 31.51378436699721
Free cash flow (dilution-adjusted): -117347000
Buyback yield (%): 0
Retained earnings: -632249000
Inventory turnover: 1.9723537269569864
Receivables turnover: 8.625465811063595
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.4057094679155306
FCF margin (%): -6.679553668042456
Rule of 40 score: -6.679553668042456
Financial ratios for CODI — annual report dated 2023-12-31
Total revenue: 1689920000
Gross profit: 674720000
Operating income: 21188000
Net income: 108647000
Capital expenditures: 55016000
Operating cash flow: 16641000
Depreciation & amortization: 129534000
Net tangible assets: -652253000
Owner earnings: 183165000
Return on net tangible assets (%): -28.081894602247903
Capex to operating income (%): 259.6564092882764
Buffett classification: The Gruesome
Stock price: 20.9
P/E ratio: 14.472849589956464
Shares outstanding: 75235966
Book value: 856425000
P/B ratio: 1.83604132224071
Market cap (USD): 1572431689.3999999
Debt to equity: 1.9521604343637797
Current ratio: 0.5872581176583828
Quick ratio: 0.3454641623568697
Interest coverage ratio: 0.19288998133733898
COGS to revenue (%): 60.07384964968756
SG&A to revenue (%): 29.706317458814617
Free cash flow (dilution-adjusted): -47826000
Buyback yield (%): 0.5939208719180371
Retained earnings: -646225000
Inventory turnover: 1.942933040387821
Receivables turnover: 9.123015380296593
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.8200044151513564
FCF margin (%): -2.8300747964400683
Revenue growth (%): -3.8074144656590447
Rule of 40 score: -6.637489262099113